相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries
Brad R. S. Broughton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Rho kinase and Ca2+ entry mediate increased pulmonary and systemic vascular resistance in L-NAME-treated rats
Jasdeep S. Dhaliwal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Ca2+ signaling in hypoxic pulmonary vasoconstriction:: effects of myosin light chain and Rho kinase antagonists
Jian Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats
Masahiko Oka et al.
CIRCULATION RESEARCH (2007)
Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats
Bao Hua Jiang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice
Kohtaro Abe et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension
Xi-qian Xing et al.
DRUG NEWS & PERSPECTIVES (2006)
ρ kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung
Thomas A. Parker et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Angiotensin II signal transduction through small GTP-binding proteins - Mechanism and significance in vascular smooth muscle cells
Haruhiko Ohtsu et al.
HYPERTENSION (2006)
Targeting Rho and Rho-kinase in the treatment of cardiovascular disease
K Budzyn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Beneficial acute effects of Rho-kinase inhibitor in patients with pulmonary arterial hypertension
K Ishikura et al.
CIRCULATION JOURNAL (2006)
Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization:: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697
DP Wilson et al.
BIOCHEMICAL JOURNAL (2005)
Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure
T Kishi et al.
CIRCULATION (2005)
Inhaled rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension
T Nagaoka et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
ROCKs as therapeutic targets in cardiovascular diseases
Yoshiyuki Rikitake et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2005)
Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats
K Abe et al.
CIRCULATION RESEARCH (2004)
Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase
KA Fagan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats
T Nagaoka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Protein kinase a in complex with rho-kinase inhibitors Y-27632, fasudil, and H-1152P: Structural basis of selectivity
C Breitenlechner et al.
STRUCTURE (2003)
Ca2+ sensitivity of smooth muscle and nonmuscle myosin II:: Modulated by G proteins, kinases, and myosin phosphatase
AP Somlyo et al.
PHYSIOLOGICAL REVIEWS (2003)
Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina
A Masumoto et al.
CIRCULATION (2002)
Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases
H Shimokawa
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans
A Masumoto et al.
HYPERTENSION (2001)
Regulation and functions of Rho-associated kinase
M Amano et al.
EXPERIMENTAL CELL RESEARCH (2000)
分享论文
